Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): an overview of current and future therapeutic strategies

Published:2020-02-03 Issue:4 Volume:14 Page:405-414
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Biondini Davide¹,Balestro Elisabetta¹,Sverzellati Nicola²,Cocconcelli Elisabetta¹,Bernardinello Nicol¹,Ryerson Christopher J.³,Spagnolo Paolo¹

Affiliation:

1. Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy

2. Section of Diagnostic Imaging, Department of Surgery, University of Parma, Parma, Italy

3. Department of Medicine, University of British Columbia and Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, Canada

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2020.1724096

Reference86 articles.

1. Idiopathic Pulmonary Fibrosis

2. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

3. The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy?

4. Forced Vital Capacity in Idiopathic Pulmonary Fibrosis — FDA Review of Pirfenidone and Nintedanib

5. Molecular Phenotypes Distinguish Patients with Relatively Stable from Progressive Idiopathic Pulmonary Fibrosis (IPF)

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pilot study of home-based monitoring for early prediction of acute exacerbations in patients with fibrosing interstitial lung diseases;Scientific Reports;2024-09-10

2. Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2024-07-04

3. Squamous metaplasia is an indicator of acute exacerbation in patients with usual interstitial pneumonia / idiopathic pulmonary fibrosis;Respiratory Investigation;2024-07

4. Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives;Multidisciplinary Respiratory Medicine;2024-06-13

5. Effect of Qingluo Yin Regulation on the TGF-β1/Smads/miR-7d/HMGA2 Signaling Pathway to Inhibit Epithelial-Mesenchymal Transformation in AE-IPF;J BIOL REG HOMEOS AG;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3